- Home
- MLGO vs NEUP Comparison
MLGO vs NEUP Comparison
Compare MLGO & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- NEUP
- Stock Information
- Founded
- MLGO 2018
- NEUP 1996
- Country
- MLGO China
- NEUP United States
- Employees
- MLGO N/A
- NEUP N/A
- Industry
- MLGO EDP Services
- NEUP
- Sector
- MLGO Technology
- NEUP
- Exchange
- MLGO Nasdaq
- NEUP Nasdaq
- Market Cap
- MLGO 15.6M
- NEUP 12.7M
- IPO Year
- MLGO N/A
- NEUP N/A
- Fundamental
- Price
- MLGO $0.61
- NEUP $7.16
- Analyst Decision
- MLGO
- NEUP Strong Buy
- Analyst Count
- MLGO 0
- NEUP 1
- Target Price
- MLGO N/A
- NEUP $21.00
- AVG Volume (30 Days)
- MLGO 39.9M
- NEUP 26.7K
- Earning Date
- MLGO 04-28-2025
- NEUP 08-15-2025
- Dividend Yield
- MLGO N/A
- NEUP N/A
- EPS Growth
- MLGO N/A
- NEUP N/A
- EPS
- MLGO 0.55
- NEUP 0.00
- Revenue
- MLGO $74,185,505.00
- NEUP $15,662,715.00
- Revenue This Year
- MLGO N/A
- NEUP N/A
- Revenue Next Year
- MLGO N/A
- NEUP N/A
- P/E Ratio
- MLGO $1.25
- NEUP $4,214.24
- Revenue Growth
- MLGO N/A
- NEUP N/A
- 52 Week Low
- MLGO $0.50
- NEUP $2.90
- 52 Week High
- MLGO $185.20
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- MLGO 33.92
- NEUP N/A
- Support Level
- MLGO $0.50
- NEUP N/A
- Resistance Level
- MLGO $0.75
- NEUP N/A
- Average True Range (ATR)
- MLGO 0.11
- NEUP 0.00
- MACD
- MLGO 0.15
- NEUP 0.00
- Stochastic Oscillator
- MLGO 36.39
- NEUP 0.00
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.